Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

BBraveheart Bio, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
B

Braveheart Bio, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
$18.55Close · Oct 8, 2026

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Aug 7, 2026ORBIMED ADVISORS LLCDirector, 10% Owner1,940,000Common Stock$58.2MBuy
Aug 7, 2026ORBIMED ADVISORS LLCDirector, 10% Owner9,132,420Common Stock$274MConversion
Aug 7, 2026Chimovits ErezDirector, 10% Owner1,940,000Common Stock$58.2MBuy
Aug 7, 2026Chimovits ErezDirector, 10% Owner9,132,420Common Stock$274MConversion
Aug 7, 2026AH Bio Fund IV, L.P.10% Owner1,100,000Common Stock$33MBuy
Aug 7, 2026AH Bio Fund IV, L.P.10% Owner9,132,420Common Stock$274MConversion
Aug 7, 2026Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner7,420,091Common Stock$222.6MConversion
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.10% Owner3,600,000Common Stock$108MBuy
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.10% Owner17,123,287Common Stock$513.7MConversion
Aug 7, 2026Lubner David CharlesDirector55,555Common Stock$1.7MBuy